| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 40.445 | 85.122 | 60.913 | 58.172 | 49.400 | 56.456 |
| Total Income - EUR | - | - | - | - | 40.460 | 87.729 | 58.966 | 60.159 | 49.459 | 56.518 |
| Total Expenses - EUR | - | - | - | - | 37.583 | 74.756 | 63.783 | 58.882 | 48.685 | 55.602 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.877 | 12.973 | -4.818 | 1.277 | 774 | 916 |
| Net Profit/Loss - EUR | - | - | - | - | 1.664 | 10.623 | -5.372 | 469 | 384 | 608 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Vadox Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 28 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 4.002 | 13.508 | 7.229 | 3.735 | 8.426 | 26.883 |
| Inventories | - | - | - | - | 1.482 | 4.436 | 2.586 | 2.474 | 3.296 | 4.612 |
| Receivables | - | - | - | - | 293 | 6 | 392 | 734 | 457 | 20.873 |
| Cash | - | - | - | - | 2.226 | 9.066 | 4.252 | 527 | 4.673 | 1.398 |
| Shareholders Funds | - | - | - | - | 1.706 | 12.296 | 6.651 | 518 | 900 | 1.503 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.324 | 1.211 | 578 | 3.217 | 7.526 | 25.381 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4799 - 4799" | |||||||||
| CAEN Financial Year |
4799
|
|||||||||
Comments - Vadox Bio S.r.l.